Company / Free Cash Flow
Bruker Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$43.3M
FY2025
5-year range
$43.3M / $243.2M
FY2021-FY2025
Trend
-68.2%
vs FY2024
Sector context
#95 of 145
Health Care
What the data says
At $43M, Bruker's free cash flow ranks #95 of 145 in the Health Care sector. Free Cash Flow has fluctuated over the past 10 years, ranging from $43M in FY2025 to $320M in FY2020.
Based on SEC 10-K filings.
$43M in FY2025 with a 5-year CAGR of -33.0%.
Declined from $243M to $43M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -33.2%
- 5-Year CAGR
- -33.0%
- 10-Year CAGR
- -
Sector benchmark
#95 of 145 in Health CareTop 66% of 145This company $43.3M Sector average $770.9M
▼
-94.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -33.0%, indicating a declining trend.
- In FY2025, free cash flow decreased 68.2% year-over-year.
- Ranks #95 out of 145 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2020.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $43.3M | -68.2% |
| FY2024 | $136.0M | -44.1% |
| FY2023 | $243.2M | +67.5% |
| FY2022 | $145.2M | -23.7% |
| FY2021 | $190.4M | -40.5% |
| FY2020 | $319.9M | +127.8% |
| FY2019 | $140.4M | -26.3% |
| FY2018 | $190.5M | +72.1% |
| FY2017 | $110.7M | +18.1% |
| FY2016 | $93.7M | -51.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026